PRODUCT PROFILE

Latest Dublin Prices

NAME
LATEST
CHANGE
Aer Lingus 2.00 0.18 more
BoI 0.32 0.00 more
CRH 18.80 0.26 more
Glanbia 12.47 0.04 more
Greencore 0.64 -0.02 more
Ind. News 0.12 0.01 more
Ryanair 9.34 -0.06 more

 

Botox maker turns down USD54bn offer

Tuesday, June 10 15:17:24

Allerganís board rejected the latest offer by Valeant Pharmaceuticals International Inc. and investor Bill Ackman, calling it undervalued.

Allergan, based in California and the maker of Botox, said in a statement that it turned down the offer of $72 a share in cash and 0.83 a share of Valeant stock.

The deal valued Allergan at about $54 billion.